A female researcher unboxing equipment and smiling at the camera

Information for applicants

Through Instrumental Access, Seeding Labs connects universities and research institutes in low- and middle-income countries with high-quality laboratory equipment.

How the program works

Seeding Labs Accepts Equipment Donations
Throughout the year, Seeding Labs solicits donations of surplus laboratory equipment and supplies from our network of 200+ equipment donors. These donors include equipment manufacturers, pharmaceutical companies, and many other types of organizations. Donations are received, inventoried, checked for quality, and stored at our warehouse near Boston, Massachusetts in the United States.

Awardees Choose Their Equipment
After they are accepted to the program, Instrumental Access awardees have an opportunity to “shop” in our available inventory during a specific 3-week period to choose the items that will comprise their shipment. Awardees use our online shopping portal to select enough equipment to fill a small (20-foot) shipping container.

Awardees contribute financially to offset program costs
Awardees pay a fee that helps to offset a portion of the program’s operating costs. We invoice for the service fee at the beginning of the shopping period, with payment due when we have agreed on the contents of the shipment.

We collaborate on shipment logistics
Just before and during the shopping period, we work closely with awardees to ensure that the shipment paperwork is in order and that we’ve provided all the information they need to navigate their country’s customs and import regulations.

Seeding Labs arranges international freight
As soon as we receive the program fee, we pack the items into a container and ship them (at our expense) to the nearest ocean port to in the awardee’s institution.

Awardees use the equipment for teaching and research
Upon arrival at the port, awardees are responsible for clearing the container through customs and arranging for ground transportation from the port to their campus. After that, it’s up to the awardee to use and maintain the equipment.

Benefits of an Instrumental Access award

Equipment and supplies
A typical Instrumental Access shipment consists of 100-150 individual items of equipment, glassware, and consumables that have been selected by our awardees to meet their specific needs for teaching and research.

What’s the value of a typical shipment? This is a complicated question for a number of reasons: the contents of every shipment are unique and highly variable; there’s no generally accepted standard for valuation of used laboratory equipment; and prices/availability vary widely depending on where you are in the world. For reference, however, the average replacement value of our shipments has historically been in the range of $300,000-$400,000 (USD).

For more information about our inventory, see below.

Membership in our global network
New awardees join a vibrant and growing global community of awardees and supporters. 

Access to additional opportunities and resources
We partner with external organizations to offer exclusive benefits and opportunities to our awardees on an ongoing basis. In the past, these opportunities have included access to plasmids, manuscript editing services, e-learning opportunities, and more.

We also do everything in our power to highlight the accomplishments of our awardees, including generating media attention if desired. We have worked with reporters to feature the work of our awardees in international media outlets such as Nature, The Boston Globe, USAID Frontlines, Forbes, and SciDevNet.com.

What is required of awardees?

Program fee
Participation in Instrumental Access is economical, but it is not free. Awardees pay a fee that helps to offset a portion of our procurement, logistics, insurance, transportation, and administrative costs.

Please note that this is a service fee; you are not purchasing the equipment from Seeding Labs. The equipment is a donation for education and research purposes.

The program fee is based on the income level of the applicant’s country:

Afghanistan, Algeria, Angola, Bangladesh, Belize, Benin, Bhutan, Bolivia, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African Republic, Chad, Côte d’Ivoire, Democratic Republic of Congo, Djibouti, Egypt, El Salvador, Eritrea, Eswatini, Ethiopia, Gambia, Ghana, Guinea-Bissau, Haiti, Honduras, India, Indonesia, Kenya, Kiribati, Kyrgyz Republic, Lao PDR, Lesotho, Liberia, Madagascar, Malawi, Mali, Micronesia, Mongolia, Morocco, Mozambique, Mauritania, Myanmar, Nepal, Nicaragua, Niger, Nigeria, Pakistan, Papua New Guinea, Philippines, Republic of the Congo, Rwanda, Samoa, São Tomé and Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, Sudan, South Sudan, Sri Lanka, Tajikistan, Tanzania, Timor-Leste, Togo, Tunisia, Uganda, Ukraine, Uzbekistan, Vietnam, West Bank and Gaza, Yemen, Zambia, Zimbabwe

Last updated 7 November 2024

Albania, American Samoa, Antigua and Barbuda, Argentina, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Chile, China, Colombia, Costa Rica, Dominica, Dominican Republic, Ecuador, Equatorial Guinea, Fiji, Gabon, Georgia, Grenada, Guatemala, Guyana, Jamaica, Jordan, Kazakhstan, Kosovo, Lebanon, Libya, Malaysia, Maldives, Marshall Islands, Mauritius, Mexico, Moldova, Montenegro, Namibia, North Macedonia, Panama, Paraguay, Peru, Poland, Romania, Serbia, Seychelles, South Africa, St. Kitts and Nevis, St. Lucia, St. Vincent and the Grenadines, Suriname, Thailand, Tonga, Trinidad and Tobago, Turkey, Turkmenistan, Tuvalu, Uruguay

Last updated 7 November 2024

Program fee payment must be made in US dollars via direct wire transfer. In rare cases where national law prohibits payment to the United States via direct wire transfer, we will consider other arrangements.

Payment is due after equipment selection is complete, so you will know the contents of your shipment before you pay the fee.

If you intend to raise funds from external sources, or if there are other unusual circumstances that apply to your situation, please contact us to discuss. Please note, however, that the program fee cannot be waived.

Other monetary costs
In addition to the program fee, awardees should budget for other costs associated with participation. They include:

  • Any costs associated with customs clearance in your country. At a minimum, this usually includes hiring an agent to handle to customs clearance process. Any costs associated with cargo inspections required by your government will be your responsibility, as will any applicable taxes or duties.
  • Local transportation of the container from the port of entry (an ocean port) to your campus.
  • Electrical power conversion if required. Many items in our inventory are configured specifically for the US electrical power grid (120V/60Hz). In most other regions of the world, these items will require voltage transformers, plug adapters, and sometimes frequency converters.
  • All costs associated with installation, calibration, maintenance, repair, and use of the equipment. 
  • Any additional costs associated with selected items that are not included in the donation. Common examples include accessories, rotors, pumps, columns,  software, and reagents. Information about what is included will be available to you at the time of selection so that you can decide for yourself whether you want to take on these costs.
  • All wire fees, banking fees, or other costs associated with payment of the program fee in US dollars.


Time and effort

Participation in Instrumental Access requires a substantial time commitment on the part of both the awarded department and the institution as a whole.

The individual who serves as primary contact can expect to devote several hours per week to coordination during the most active phases of shipment preparation, such as the equipment selection period, and for required communication and reporting to Seeding Labs.

In addition, it is typical for a number of other offices and individuals from the awarded institution to be involved in different aspects of the collaboration, including procurement, finance, legal, public relations, and senior leadership.

Our donation process can require considerable flexibility and patience on the part of everyone involved.

Who is eligible to apply?

  1. Institution type: Applicants must be one of three types of institutions:
    • Colleges, universities, polytecnics, or other degree-granting institutions of tertiary education
    • University-affiliated research institutes
    • Public research institutes that are actively engaged in research training

    For colleges or universities, we typically partner with a single academic department, as this is the scale at which the program is designed to meet equipment needs.

    However, we will consider working with other sub-units (such as a school or college, two collaborating departments, or a central lab facility) on a case-by-case basis. Please contact us to discuss your situation.

    Individuals, lab groups, and research projects are not eligible to apply on their own.

    Hospitals, clinics, primary and secondary schools, for-profit companies, and NGOs not of the types listed above are not eligible.

  2. Geography: Applicant institutions must be located in an eligible country.

Afghanistan, Angola, Bangladesh, Benin, Bhutan, Bolivia, Burkina Faso, Burundi, Cambodia, Cameroon, Central African Republic, Chad, Côte d’Ivoire, Comoros, Democratic Republic of Congo, Djibouti, Egypt, Eritrea, Eswatini, Ethiopia, Gambia, Ghana, Guinea-Bissau, Haiti, Honduras, India, Jordan, Kenya, Kiribati, Kyrgyz Republic, Lao PDR, Lebanon, Lesotho, Liberia, Madagascar, Malawi, Mali, Micronesia, Morocco, Mozambique, Mauritania, Namibia, Nepal, Nicaragua, Niger, Nigeria, Pakistan, Papua New Guinea, Philippines, Republic of the Congo, Rwanda, São Tomé and Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, Sudan, South Sudan, Sri Lanka, Tajikistan, Tanzania, Timor-Leste, Togo, Tunisia, Uganda, Uzbekistan, Vanuatu, Vietnam, West Bank and Gaza, Yemen, Zambia, Zimbabwe

Last updated July 2025

Albania, Algeria, American Samoa, Antigua and Barbuda, Argentina, Armenia, Azerbaijan, Belarus, Belize, Bosnia and Herzegovina, Botswana, Brazil, Bulgaria, Cabo Verde, Chile, China, Colombia, Costa Rica, Dominica, Dominican Republic, Ecuador, El Salvador, Equatorial Guinea, Fiji, Gabon, Georgia, Grenada, Guatemala, Guyana, Indonesia, Jamaica, Kazakhstan, Kosovo, Libya, Malaysia, Maldives, Marshall Islands, Mauritius, Mexico, Moldova, Mongolia, Montenegro, Namibia, North Macedonia, Panama, Paraguay, Peru, Poland, Romania, Samoa, Serbia, Seychelles, South Africa, St. Kitts and Nevis, St. Lucia, St. Vincent and the Grenadines, Suriname, Thailand, Tonga, Trinidad and Tobago, Turkey, Turkmenistan, Tuvalu, Ukraine, Uruguay

Last updated July 2025

  1. Equipment needs: Applicants should have needs for a broad and diverse set of equipment and supplies in our inventory (for more information, please see About Our Inventory below). We are typically a good fit for departments of biology, chemistry, and closely related applied fields such as biomedical sciences, agricultural sciences, environmental sciences, and biological or chemical engineering. We do not generally have appropriate equipment for physics, computer science, mathematics, business, social sciences, or mechanical/civil/electrical engineering. In addition, we will probably not be a good fit if your institution is primarily looking for just one or two very specific items, .
  2. Ability to meet program requirements: Applicants must be able and willing to meet all program requirements, including ability to pay the program fee. For more on program requirements, see the previous section. If you have any questions about eligibility or would like to discuss your situation in more detail, you are strongly encouraged to contact us.

About our inventory

What types of items can be found in the Seeding Labs inventory?
Our inventory consists of new and gently-used surplus equipment provided by our equipment donors. We accept instruments, glassware, and consumables that are commonly used in biology and chemistry labs.

We do not solicit and rarely or never accept:

  • Equipment specialized for field or agricultural research
  • Clinical/medical equipment and supplies
  • Industrial scale or high-throughput equipment
  • Equipment specialized for physics or engineering (except chemical and biological)
  • Computers, audiovisual equipment, vehicles, furniture, and office supplies
  • Reagents and chemicals

You can review our target list for equipment donors here.

Please note, however, that there are many categories of items that we actively seek but do not receive in sufficient quantity to meet demand from our awardees.

What will be available when it’s your turn to select?
The truth is that we can’t say exactly. We always have a wide variety of equipment and supplies available, but our inventory changes as new donations come in and other shipments are fulfilled.

What we have on hand today is not what we’ll have next week, let alone next year. For this reason, we can’t provide you with a list of what will be available until it’s your turn to select. In addition, and importantly, we can’t guarantee the availability of any specific item, make, or model.

We provide excellent return on investment, but we’re only a good fit for groups with needs that are broad and flexible enough to take advantage of what we can offer.

What is the condition of the equipment?
Since most of our inventory is gently used, quality control is particularly important. We have multiple processes in place to ensure the quality of equipment in our inventory.

First, we work closely with our donors to ensure quality. We do not accept an item unless the donor can ensure us that it is fully functional at the time of donation. We do not accept items that are partially-functional or in need of repairs.

Second, for items that require specialized reagents, software, or advanced technical support, we check with the manufacturer to verify that the item is not obsolete—meaning that it is still supported by the manufacturer.

We do not usually accept obsolete items, although we do make a handful of exceptions for items that are in high demand despite being obsolete.

Third, we perform functional testing as feasible when the items are received. We have a testing protocol for every category of equipment that we accept.

However, our testing is currently limited to what can be accomplished in a warehouse setting. We do not have access to 240v power lines, water, gas, reagents, samples, standards, software, or skilled technicians.

What this means in practice is that the more complex an item is, the less likely it is that we’ll be able to test it fully. For many of the most sophisticated analytical instruments in our inventory, we have to rely primarily on a visual inspection.

Our goal is for every item we ship to be fully functional and ready to use, and we’re always looking for ways to improve our quality control processes. However, the reality is that we aren’t perfect. It’s normal for there to be issues with a few items from every shipment, and awardees should anticipate this.

Because we are not a manufacturer, we are unable to offer refunds, replacements, or other warranties. Awardees accept their equipment as is.

Application and review process

  1. Submit a written application
    Written applications will be reviewed for eligibility, completeness, and fit for the program. We are looking for awardees who can meet all program requirements and are poised to make good use of what we can provide: a container full of laboratory equipment and supplies to be selected from our inventory.
  2. Introductory conversation with Seeding Labs
    Following application review, top-scoring applicants will be invited to speak with us about their objectives, existing infrastructure and expertise, and equipment needs.
  3. Accept a program slot
    Program slots, or specific time periods for equipment selection and subsequent payment of the program fee, will be offered to qualified candidates as they become available, typically with a 3-6 month time lag.
  4. Sign letter of agreement
    New awardees and Seeding Labs sign a detailed Letter of Agreement that describes the relationship and spells out the roles and responsibilities of both parties in detail. This document must be signed by an official who is authorized to enter into agreements on behalf of the entire institution, typically the Vice Chancellor or equivalent.

You can support stronger science around the world with a gift today.

Bruce Walker, MD

Bruce D. Walker, MD
Founding Director, Ragon Institute

 

Dr. Bruce D. Walker is a physician-scientist and T cell immunologist, the founding Director of the Ragon Institute of Mass General Brigham, MIT and Harvard, a Howard Hughes Medical Institute Investigator, a Professor of Medicine at Harvard Medical School, and Professor of the Practice of Medicine at MIT.  

Dr. Walker received a BS in chemistry in 1980 from the University of Colorado, Boulder, also attending the Swiss Federal Technical Institute (ETH), and his MD from Case Western Reserve University. He performed his internship and residency training in internal medicine at MGH and Harvard Medical School, where he also completed an internship in pathology and specialty training in infectious disease. He is a native of Boulder, Colorado, and is board-certified in both internal medicine and infectious disease.  Together with Arlene Sharpe, he is also the co-director of the Massachusetts Consortium on Pathogen Readiness (MassCPR), a collaboration among more than 800 local scientists focused on pandemic preparedness from Harvard, MIT, BU, Tufts, UMass, the academic teaching hospitals, and the Department of Health in Massachusetts. He is a member of the National Academy of Medicine and the American Academy of Arts and Sciences.

Dr. Walker’s laboratory studies T cell responses to chronic viral infections, using HIV as a model system.  His lab focuses on learning from patients to determine how the body fights back against viral infections using HIV as a highly relevant example, trying to uncover mechanisms by which it succeeds and, importantly, why it usually fails.  They study blood samples from persons with chronic HIV infection as well as from elite controllers, persons who are able to control HIV infection to undetectable levels without the need for antiretroviral therapy (ART).  His work extends to international collaborations, particularly with investigators at the Nelson Mandela School of Medicine at the University of KwaZulu-Natal in Durban, South Africa, where Dr. Walker helped catalyze the creation of two research institutes.  

Jonathan Spector, MD

Jonathan Spector, MD
Head of Global Health Strategy and Access, Novartis Biomedical Research

Jonathan M. Spector MD MPH has practiced pediatrics and public health for 20+ years. His clinical activities span fieldwork with Médecins Sans Frontières in remote Africa to intensive newborn care at Massachusetts General Hospital. His interest in health systems fueled a portfolio of research at Harvard School of Public Health to support maternal and newborn health in low resource settings. As part of that work, he led the design and early testing of the World Health Organization’s Safe Childbirth Checklist. Jonathan later directed the opening of Lao Friends Hospital for Children, the first comprehensive pediatric medical center in northern Lao PDR. Now at Novartis, he leads portfolio strategy, partnering, and access-to-medicine solutions for the Novartis Global Health research unit—helping to bring novel therapies “bench-to-bedside” to address major unsolved health challenges.

Aravinda Souza

Aravinda Souza
Chief Marketing Officer, RefAssured and Seeding Labs Board Clerk

Aravinda Souza is a communications and content marketing leader for high-growth, agile technology companies who value customer experience as paramount. She thrives on being a player-coach in high-performing, nurturing teams and prioritizing both speed and quality simultaneously. As a writer, speaker, researcher, and storyteller, and Vinda is passionate about communicating across all platforms.

Krish Ramanathan, PhD

Krish Ramanathan, PhD
Chief of Staff and Head of Strategic Development, Gates Medical Research Institute

Krishnan (Krish) Ramanathan is Chief of Staff and Head of Strategic Development at the Gates Medical Research Institute (Gates MRI), a nonprofit affiliate of the Gates Foundation, where he leads development programs for its drug and vaccine candidates. Krish has more than 25 years of integrated pharmaceutical and biotechnology experience, including leadership in development programs across vaccines and therapeutics. Prior to joining the Gates MRI, Krish served as Senior Vice President and Head of Immunology Portfolio & Assets at Johnson & Johnson Innovative Medicines R&D, where he led teams overseeing early- and late-stage development. Before joining J&J, Krish held leadership roles at Novartis spanning multiple therapeutic areas, leading teams to successful regulatory approvals. Krish holds a Ph.D. in Biomedical Engineering from Johns Hopkins University. He has a M.S.E. in Biomedical Engineering from John Hopkins University and an undergraduate degree in Mechanical Engineering from the Indian Institute of Technology, Chennai.
Al Ozonoff, PhD

Al Ozonoff, PhD
Director of Pandemic Preparedness, the Broad Institute, Associate Professor of Pediatrics, Harvard Medical School

Al Ozonoff, PhD, CPPS is Senior Advisor to Dr. Pardis Sabeti and Chief of Staff of the Sabeti Lab. In these roles, he provides administrative leadership and senior scientific expertise across the full range of lab activities and research. He provides further programmatic support as the U.S. Director for the Sentinel Program. Al is Associate Professor of Pediatrics at Harvard Medical School and a faculty scientist within the Precision Vaccines Program at Boston Children’s Hospital.

Al applies his training in mathematics, statistics, epidemiology, and data science in pursuit of population-based improvement in the health of children and adults. His research focuses on the development and application of methods for surveillance of health and disease. As a surveillance methodologist, he is most engaged in areas of public health surveillance, infectious disease surveillance, and hospital-based surveillance with an emphasis on patient safety and healthcare quality.

Al’s graduate and post-doctoral training was in mathematics (University of California, Santa Barbara, under D. Darren Long) and biostatistics (Harvard School of Public Health, under Marcello Pagano). He has co-authored over 200 peer-reviewed publications throughout more than 20 years of research experience. He was Principal Investigator of two R01 grant awards: a 3-year project funded by the Centers for Disease Control and Prevention (CDC) BioSense Program, “Improving syndromic surveillance by data integration” (R01 PH000021-02), and a 5-year project funded by the Agency for Healthcare Research and Quality (AHRQ), “Patient safety surveillance using machine learning and free text clinical” (R01 HS026246-01A1).

As a leading expert during the early phases of the pandemic, Al led the Clinical and Data Coordinating Center for IMPACC, a national immunophenotyping study of COVID-19 funded by the National Institute for Allergies and Infectious Disease (NIH/NIAID). In 2016-17, he was one of 12 Harvard Medical School Fellows in Bioethics.

Outside of work, Al enjoys spending time with his family and learning from teachers in contemplative traditions. He has played semi-professional football for over 25 years, most recently with the Randolph Oilers of the East Coast Football League.

Michelle Niescierenko, MD

Michelle Niescierenko, MD
Director of the Global Health Program, Boston Children’s Hospital

Michelle Niescierenko, MD, MPH is a Pediatric Emergency Medicine physician, director of the Global Health Program at Boston Children’s Hospital and Health Specialist with Avenir Analytics. The Boston Children’s Global Health Program works to improve child health globally through partnerships for clinical quality improvement, education, research and advocacy in over 30 countries around the world. ??Avenir Analytics health focus on high quality humanitarian health systems interventions.

She has experience in pediatric care and program development in China, Bolivia, Lesotho, Guatemala, Liberia, Indonesia, Uganda, Saudi Arabia, Turkey and Syria. In Liberia she provided pediatric humanitarian aid in the immediate post-conflict setting partnering local remaining infrastructure to US academic institutions for the last 10 years. Through these partnerships, sustainable programs for health system rebuilding including physician education and care for vulnerable children were developed in Liberia. During the 2014-2015 Ebola outbreak she lead the Liberian hospital public health response utilizing a rapid deployment of training done by local healthcare workers. This work continued into Liberia’s recovery phase with implementation of a national program for hospital quality improvement and emergency care training. Her particular areas of interest are in the provision of healthcare in humanitarian settings through system development, the development of emergency care systems for children as well as the role of children in humanitarian crises.

Harvey Lodish

Harvey Lodish, PhD
Professor of Biology, Massachusetts Institute of Technology and Founding Member, Whitehead Institute, and Seeding Labs Board Member

Harvey Lodish has been a leader in molecular cell biology as well as a biotechnology entrepreneur for over five decades. Much of his early research focused on the regulation of messenger RNA translation and the biogenesis of plasma membrane glycoproteins. Beginning in the 1980s, his research focused on cloning and characterizing many proteins, microRNAs, and long noncoding RNAs important for red cell development and function. His laboratory was the first to clone and sequence mRNAs encoding many hormone receptors, mammalian glucose transport proteins, and proteins important for adipose cell formation and function. He went on to identify and characterize several genes and proteins involved in insulin resistance and stress responses in adipose cells. Over the years, he has mentored hundreds of undergraduates, PhD and MD/PhD students, and postdoctoral fellows, and continues to teach award-winning undergraduate and graduate classes on biotechnology. 

Chad Jackson

Chad R. Jackson, PhD
Senior Director of Preclinical and Translational Research, Foundation Fighting Blindness, Seeding Labs Board Chair

Chad Jackson, PhD is a translational science executive focused on developing breakthrough therapies for inherited retinal diseases (IRDs), dry age-related macular degeneration (AMD), and other vision disorders. With a background in visual neuroscience (Ph.D., Emory) and over a decade of experience spanning the nonprofit, federal, and academic sectors, he specializes in advancing complex therapeutics—like gene therapies and regenerative approaches—from lab to clinic.

At the Foundation Fighting Blindness, Dr. Jackson leads a $50M+ portfolio of preclinical and early clinical-stage programs, including a first-in-kind $46M whole eye transplant effort funded by ARPA-H. His role blends scientific strategy, regulatory readiness, funding acquisition, and multi-site team leadership. He has conducted scientific due diligence for promising biotech startups, advised C-suite leadership on go/no-go decisions, and forged partnerships across academic labs, CROs, and government agencies.

Previously, he supported national R&D priorities through roles at DARPA, the Office of the Secretary of Defense, and the U.S. State Department. These experiences sharpened his ability to navigate federal innovation ecosystems and scale novel technologies for societal impact.

Ina Breuer

Ina Breuer
Executive Director, Network of Engaged International Donors

Ina Jamuna Breuer is Executive Director of NEID Global, which is a national peer-to-peer learning community of global donors, social investors, and family foundations. NEID Global’s mission is to convene and empower donors to help address the world’s big problems and does so through 50 events per year, two Giving Circles focused on core issues of international development, and a bi-annual Symposium.

NEID offers its members a journey that helps them learn, connect, inspire, and act. This journey entails providing members access to experts, to other global philanthropists and to safe spaces to learn from each other.

Previously Ina was the Executive Director of Beyond Conflict, where she worked for 17 years to help leaders in the Middle East, Central America, Northern Ireland, the Balkans, and South Asia address difficult challenges relating to reconciliation and change. At Beyond Conflict Ina launched the Neuroscience and Social Conflict Initiative in 2008, which now forms the core of Beyond Conflict’s work and has led to a new area of inquiry at the intersection of brain science and conflict resolution. Prior to BC, Ina was the Assistant Director of the Transregional Center for Democratic Studies at the New School for Social Research in New York. In the early 1990s TCDS was a hub for dissidents from Eastern Europe and was focused on helping rebuild civil society and the political culture needed for democracies to flourish in the former communist region. Ina began her career at the Foundation for Civil Society, where she was involved in educational and environmental programming in the Czech Republic and Slovakia. She completed her studies at Northwestern University, the Free University of Berlin and the New School for Social Research.  Ina is a German citizen that was born and raised in India and South Korea. She recently also became a US national. 

Isabella Marti Headshot

Isabella Marti
Development Fellow

Isabella is a senior Endicott College student majoring in biology/ biotechnology from Dumont, NJ. She is passionate about safety, compliance, and access to various types of laboratory equipment. During her semester-long internship at Seeding Labs, Isabella will be standardizing and automating engagement efforts, supporting all phases of the donor cycle, and working hands-on with the fundraising team. 

Paul Hohenberger

Paul Hohenberger
Director of Individual Giving

Paul is responsible for individual outreach to increase philanthropic support for Seeding Labs. He is an experienced fundraising professional with broad knowledge and understanding of resource development and advancement in major research universities and public trusts. 

In previous roles at The University of Massachusetts, MIT, Harvard University, and the Pew Charitable Trusts, Paul cultivated relationships within the philanthropic community, garnering support for programs and priorities spanning nuclear engineering, global health, climate science/energy, and demographic and survey research.

Paul’s educational background includes a bachelor’s degree in political science and history from the University of Massachusetts at Amherst. He is active in his alma mater, serving on the Department of Political Science Advisory Board, and was a former board member of the UMass Alumni Association. 

Additionally, he has completed professional certificate programs at the T.H. Chan Harvard School of Public Health and MIT, enhancing his expertise in policy, politics, and innovation.

Eaint Kyaw headshot

Eaint Kyaw
Logistics Intern

Eaint is currently a sophomore at Bunker Hill Community College, majoring in Biological Science with plans to transfer in the Fall of 2025. She is originally from Myanmar, a developing country where she has witnessed the challenges scientists face due to limited access to laboratory equipment. This experience has inspired her to contribute her skills and perspective to the Seeding Labs team in support of scientists in developing countries.

Jennifer Raymond

Jennifer Raymond
Director of Corporate Relations

Jennifer builds and stewards Seeding Labs’ partnerships with corporations and other life science institutions. Our partners’ financial and lab equipment contributions help support universities and research institutions in under-resourced settings.


When these talented scientists, researchers, and educators have the resources they need to create and maintain strong scientific institutions, new solutions are created for both local development needs and global challenges.


Before joining Seeding Labs, Jennifer raised funds and engaged constituents for

the Smithsonian Astrophysical Observatory, the Boston Symphony Orchestra, and Brandeis University. She graduated from Wellesley College with a BA in French studies.

Manisha Patel

Manisha Patel
Scientific Director

Manisha uses her scientific expertise to implement the equipment-related aspects of Seeding Labs’ programs and plays a key role in Instrumental Access.

She provides support to Instrumental Access awardees, helping them choose the instruments that best meet their research and teaching goals. She also advises the Corporate Relations team on equipment that would be useful in our awardees’ labs.

Manisha has extensive experience in managing academic research labs with knowledge spanning lab setup, compliance, and equipment training. Most recently, she oversaw labs at Harvard University.

For the past decade, Manisha directed an undergraduate internship program focused on one of her passions:  diversity and inclusion in STEM. She holds a BS in ecology from Rutgers University and an MS in ecology from the University of Vermont.

Micaela Leaska

Micalea Leaska
Programs Specialist,
Metrics & Evaluation

Micalea works with the Programs team to develop and implement metrics and evaluation tools, and to monitor the worldwide impact of Instrumental Access. She compiles and analyzes quantitative data and qualitative stories that exemplify our mantra, “talent is everywhere.”

Her prior work experience includes consulting for the World Bank, working on Water Security Assessments for Peru and Central America, and improving access to safe water in rural Ecuadorian communities with the nonprofit WaterStep.

Micalea holds a BA from Saint Michael’s College and completed her Master’s degree in Climate Change and Global Sustainability from SIT Graduate Institute, where she studied global science issues alongside scientists, stakeholders, and community members in Iceland, Tanzania, and Ecuador.

Chiudo Ehirim

Chiudo Ehirim
Instrumental Access
Consultant

After completing an Atlas Corps Fellowship with Seeding Labs, Chiudo now provides support to our Instrumental Access partners from his Rumines Ltd. office in Lagos, Nigeria. Chiudo is CEO of Rumines, an environmental technology and management consulting company.

Prior to his fellowship, Chiudo was a country manager for Nigeria with Climate Scorecard, a US-based organization that monitors how the top 25 greenhouse gas-emitting countries implement the Paris Agreement on climate change.

Chiudo earned a BS in pure and industrial chemistry from the University of Nigeria and a Master’s of Science in environmental technology and management from the University of Port Harcourt in Nigeria.

David Borman

David Borman, PhD
Communications
Director

David works to highlight the innovation and scientific successes of Instrumental Access awardees. In telling these scientists’ stories, he helps to show the global impact of the Seeding Labs mission.

Prior to joining Seeding Labs, David worked as the alumni affairs director for Brevard College in North Carolina and managed communications for Kids Center for Pediatric Therapies, a nonprofit in Louisville, Kentucky, that provides services to children with special needs.

David earned his PhD in English from the University of Miami. He holds an MA in English from the University of Louisville and a BA in English from Bellarmine University.

Christine Srivastava

Christina Viola Srivastava

Vice President of Programs

Christina is responsible for program development, planning, and implementation at Seeding Labs. 

Christina has experience as a research program evaluator and science policy analyst. She’s held roles with the consulting firm Abt Associates, Inc. and the Science and Technology Policy Institute.

Prior to entering the consulting world, Christina worked for the Boston-area nonprofits Alliance for the Prudent Use of Antibiotics and Urban Ecology Institute. She holds an undergraduate degree in biology from Swarthmore College

Rick Sherman

Rick Sherman

Vice President of Philanthropy

Rick is responsible for the fundraising activities at Seeding Labs, engaging with corporations, foundations, and individuals to increase their financial and equipment donations to the organization.

Prior to joining Seeding Labs, Rick spent 17 years working in a similar capacity at a number of science-focused organizations, including Keystone Symposia, the Carnegie Institution for Science, and the Chemical Heritage Foundation (now the Science History Institute).

Rick earned an MS in Finance from Drexel University, and a BS in Paper Science and Engineering from State University of New York College of Environmental Science and Forestry.

David Qualter

Vice President of Operations

David is responsible for global logistics at Seeding Labs, overseeing the efficient movement of lab equipment worldwide.

He joined Seeding Labs from Image Arts, a subsidiary of Hallmark Cards, where he provided logistics direction for the company with $110 million in annual sales.

He brings 20 years of supply chain management experience with in-depth knowledge of international logistics, warehouse execution, and distribution center operations.

Originally an art student at Southeastern Massachusetts University, David now uses his creative talents to develop logistics strategies that produce operational efficiencies and quality customer service.

Melissa P. Wu, PhD

Melissa P. Wu, PhD

Chief Executive Officer

Please direct speaking requests to media@seedinglabs.org

Melissa is the CEO and a co-founder of Seeding Labs. She began as a volunteer leader of the Harvard Medical School student group; later, as a founding board member, she supported its transition to a nonprofit organization. In 2014, she joined the staff of Seeding Labs, leading the USAID-sponsored $3M scale-up of the Instrumental Access program. In 2019, Melissa became CEO, committed to increasing capacity for developing countries to use science. 

Operating with a deep belief in the power of science to transform lives, Melissa has dedicated her career to creating scientific research opportunities for historically underrepresented and excluded communities. In addition to roles at Harvard and the BioBuilder Educational Foundation, Melissa has mentored many students in the sciences through programs at the Journal of Emerging Investigators, Harvard University, Boston Children’s Hospital, and MIT.

Melissa earned a PhD in Cellular and Developmental Biology from Harvard University and holds an SB in Biology from the Massachusetts Institute of Technology.